Measuring Coverage in MNCH: Population HIV-Free Survival among Children under Two Years of Age in Four African Countries

English version České info

Background:
Population-based evaluations of programs for prevention of mother-to-child HIV transmission (PMTCT) are scarce. We measured PMTCT service coverage, regimen use, and HIV-free survival among children ≤24 mo of age in Cameroon, Côte D'Ivoire, South Africa, and Zambia.

Methods and Findings:
We randomly sampled households in 26 communities and offered participation if a child had been born to a woman living there during the prior 24 mo. We tested consenting mothers with rapid HIV antibody tests and tested the children of seropositive mothers with HIV DNA PCR or rapid antibody tests. Our primary outcome was 24-mo HIV-free survival, estimated with survival analysis. In an individual-level analysis, we evaluated the effectiveness of various PMTCT regimens. In a community-level analysis, we evaluated the relationship between HIV-free survival and community PMTCT coverage (the proportion of HIV-exposed infants in each community that received any PMTCT intervention during gestation or breastfeeding). We also compared our community coverage results to those of a contemporaneous study conducted in the facilities serving each sampled community. Of 7,985 surveyed children under 2 y of age, 1,014 (12.7%) were HIV-exposed. Of these, 110 (10.9%) were HIV-infected, 851 (83.9%) were HIV-uninfected, and 53 (5.2%) were dead. HIV-free survival at 24 mo of age among all HIV-exposed children was 79.7% (95% CI: 76.4, 82.6) overall, with the following country-level estimates: Cameroon (72.6%; 95% CI: 62.3, 80.5), South Africa (77.7%; 95% CI: 72.5, 82.1), Zambia (83.1%; 95% CI: 78.4, 86.8), and Côte D'Ivoire (84.4%; 95% CI: 70.0, 92.2). In adjusted analyses, the risk of death or HIV infection was non-significantly lower in children whose mothers received a more complex regimen of either two or three antiretroviral drugs compared to those receiving no prophylaxis (adjusted hazard ratio: 0.60; 95% CI: 0.34, 1.06). Risk of death was not different for children whose mothers received a more complex regimen compared to those given single-dose nevirapine (adjusted hazard ratio: 0.88; 95% CI: 0.45, 1.72). Community PMTCT coverage was highest in Cameroon, where 75 of 114 HIV-exposed infants met criteria for coverage (66%; 95% CI: 56, 74), followed by Zambia (219 of 444, 49%; 95% CI: 45, 54), then South Africa (152 of 365, 42%; 95% CI: 37, 47), and then Côte D'Ivoire (3 of 53, 5.7%; 95% CI: 1.2, 16). In a cluster-level analysis, community PMTCT coverage was highly correlated with facility PMTCT coverage (Pearson's r = 0.85), and moderately correlated with 24-mo HIV-free survival (Pearson's r = 0.29). In 14 of 16 instances where both the facility and community samples were large enough for comparison, the facility-based coverage measure exceeded that observed in the community.

Conclusions:
HIV-free survival can be estimated with community surveys and should be incorporated into ongoing country monitoring. Facility-based coverage measures correlate with those derived from community sampling, but may overestimate population coverage. The more complex regimens recommended by the World Health Organization seem to have measurable public health benefit at the population level, but power was limited and additional field validation is needed.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Measuring Coverage in MNCH: Population HIV-Free Survival among Children under Two Years of Age in Four African Countries. PLoS Med 10(5): e32767. doi:10.1371/journal.pmed.1001424
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001424

Souhrn

Zdroje

1. Joint United Nations Programme on HIV/AIDS (2010) Report on the global AIDS epidemic 2010. New York: Joint United Nations Programme on HIV/AIDS.

2. Joint United Nations Programme on HIV/AIDS (2011) Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive. New York: Joint United Nations Programme on HIV/AIDS.

3. LallemantM, ChangS, CohenR, PecoulB (2011) Pediatric HIV—A neglected disease? N Engl J Med 365: 581–583.

4. CooperER, CharuratM, MofensonL, HansonC, PittJ, et al. (2002) Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr 29: 484–494.

5. SpensleyA, SripipatanaT, TurnerA, HoblitzelleC, RobinsonJ, et al. (2009) Preventing mother-to-child transmission of HIV in resource-limited settings: The Elizabeth Glaser Pediatric AIDS Foundation experience. Am J Public Health 99: 631–337.

6. StringerEM, ChiBH, ChintuN, CreekTL, EkoueviDK, et al. (2008) Monitoring effectiveness of programmes to prevent mother-to-child HIV transmission in lower-income countries. Bull World Health Organ 86: 57–62.

7. ReithingerR, MegazziniK, DurakoSJ, HarrisDR, VermundSH (2007) Monitoring and evaluation of programmes to prevent mother to child transmission of HIV in Africa. BMJ 334: 1143–1146.

8. World Health Organization (2011) Towards the elimination of mother-to-child transmission of HIV: Report of a WHO technical consultation. Available: http://www.who.int/hiv/pub/mtct/elimination_report/en/index.html. Accessed 20 November 2012.

9. SchoutenEJ, JahnA, MidianiD, MakombeSD, MnthambalaA, et al. (2001) Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: Time for a public health approach. Lancet 378: 282–284.

10. World Health Organization (2010) Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: recommendations for a public health approach. Geneva: World Health Organization.

11. World Health Organization (2012) Programmatic update: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Geneva: World Health Organization.

12. MateKS, BennettB, MphatsweW, BarkerP, RollinsN (2009) Challenges for routine health system data management in a large public programme to prevent mother-to-child HIV transmission in South Africa. PLoS ONE 4: e5483 doi:10.1371/journal.pone.0005483.

13. EkoueviDK, KarcherS, CoffiePA (2011) Strengthening health systems through HIV monitoring and evaluation in sub-Saharan Africa. Curr Opin HIV AIDS 6: 245–250.

14. Hayashi C (2009) International guidance on methods to measure PMTCT impact [abstract]. 6th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention; 17–20 July 2011; Rome, Italy.

15. StringerEM, EkoueviDK, CoetzeeD, TihP, CreekTL, et al. (2010) Coverage of nevirapine-based services to prevent mother-to-child transmission in four African countries. JAMA 304: 293–302.

16. StringerJSA, SinkalaM, GoldenbergR, VermundS, AcostaE (2003) Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1. Lancet 362: 667–667.

17. RollinsN, MzoloS, MoodleyT, EsterhuizenT, van RooyenH (2009) Universal HIV testing of infants at immunization clinics: An acceptable and feasible approach for early infant diagnosis in high HIV prevalence settings. AIDS 23: 1851–1857.

18. Goga A, Dinh T-H, Jackson D, The SAPMTCTE Study Group (2010) Evaluation of the effectiveness of the national prevention of mother-to-child transmission (PMTCT) programme on infant HIV measured at six weeks postpartum in South Africa, 2010. Cape Town: South African Medical Research Council. Available: http://www.doh.gov.za/docs/reports/2012/pmtcteffectiveness.pdf. Accessed 16 November 2012.

19. CoffiePA, KanhonSK, TourH, HapsatouT, Ettiegne-TraoréV, et al. (2011) Nevirapine for the prevention of mother-to-child transmission of HIV: A nation-wide coverage survey in Côte d'Ivoire. J Acquir Immune Defic Syndr 57 (Suppl 1)

S3–S8.

20. EkoueviDK, StringerE, CoetzeeD, TihP, CreekT, et al. (2012) Health facility characteristics and their relationship to coverage of PMTCT of HIV services across four African countries: The PEARL Study. PLoS ONE 7: e29823 doi:10.1371/journal.pone.0029823.

21. StinsonK, BoulleA, SmithPJ, StringerEM, StringerJSA, et al. (2012) Coverage of the prevention of mother-to-child transmission programme in the Western Cape, South Africa using cord blood surveillance. J Acquir Immune Defic Syndr 60: 199–204.

22. Central Statistical Office, Ministry of Health in Zambia, Tropical Diseases Research Centre, University of Zambia, Macro International (2009) Zambia Demographic and Health Survey 2007. Calverton (Maryland): Central Statistical Office and Macro International. Available: http://www.measuredhs.com/pubs/pdf/FR211/FR211[revised-05-12-2009].pdf. Accessed 20 November 2012.

23. United Nations Children's Fund (2013) Statistics and monitoring: South Africa—delivery care coverage (%), institutional delivery (2006–2010). New York: United Nations Children's Fund.

24. United Nations Children's Fund (2013) Statistics and monitoring: Zambia—delivery care coverage (%), institutional delivery (2006–2010). New York: United Nations Children's Fund.

25. United Nations Children's Fund (2013) Statistics and monitoring: Cameroon—delivery care coverage (%), institutional delivery (2006–2010). New York: United Nations Children's Fund.

26. United Nations Children's Fund (2013) Statistics and monitoring: Côte d'Ivoire—delivery care coverage (%), institutional delivery (2006–2010). New York: United Nations Children's Fund.

27. RutonH, MugwanezaP, ShemaN, LyambabajeA, de Dieu BizimanaJ, et al. (2012) HIV-free survival among nine- to 24-mo-old children born to HIV-positive mothers in the Rwandan national PMTCT programme: a community-based household survey. J Int AIDS Soc 15: 4.